Artigo
PRODUCTION AND MARKETING OF DRUGS IN BRAZIL
Fecha
1991-01-01Registro en:
Journal Of Clinical Epidemiology. Oxford: Pergamon-elsevier Science Ltd, v. 44, Suppl. 2, p. S21-S28, 1991.
0895-4356
10.1016/0895-4356(91)90108-L
WOS:A1991FT73300004
Autor
Castelo Filho, Adauto [UNIFESP]
Colombo, Arnaldo Lopes [UNIFESP]
Holbrook, A. M.
Institución
Resumen
Brazil is typical of many developing countries in its struggle to provide basic healthcare for its citizens in face of national economic instability. Since pharmaceuticals represent a major component of modern healthcare, their production, regulation and use become an area of concern.It appears that any change in the current production patterns will require a major commitment from governments, understanding external economic pressures. There are pros and cons in a policy directed towards pharmaceutical self-sufficiency. Aside from production, efforts directed towards extending access to essential drugs and improving the appropriateness of use, would appear to be warranted.